Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (11-20 of 339) with videos related to

Pageof 34
Sort By:
Critical Reviews in Oncology/Hematology|February 14, 2006
Fulvestrant ('Faslodex'): current and future role in breast cancer managementAnthony Howell
Nature Human Behaviour|July 7, 2022
Socio-economic impacts of scaling back a massive payments for ecosystem services programme in ChinaAnthony Howell
Reviews on Recent Clinical Trials|May 14, 2008
The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancerAnthony Howell
Best Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
The endocrine prevention of breast cancerAnthony Howell
BMC Medicine|November 18, 2010
Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?Anthony Howell
Cell Cycle (Georgetown, Tex.)|September 14, 2011
Defining bad stroma in human breast tumorsAnthony Howell
Behavioral Sciences (Basel, Switzerland)|January 21, 2017
Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects-A Narrative Review of Human and Animal EvidenceMichelle Harvie, Anthony Howell
Nature Medicine|November 29, 2002
Breast cancer: aromatase inhibitors take on tamoxifenMitch Dowsett, Anthony Howell
Breast Cancer Research : BCR|November 13, 2004
Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensAnthony Howell, Mitch Dowsett
Breast Cancer Research : BCR|December 25, 2009
Risk factors. Introduction to Session 1Anthony Howell, Jack Cuzick
Pageof 34

Showing results (11-20 of 339) with videos related to

Sort By:
Pageof 34
Critical Reviews in Oncology/Hematology|February 14, 2006
Fulvestrant ('Faslodex'): current and future role in breast cancer managementAnthony Howell
Nature Human Behaviour|July 7, 2022
Socio-economic impacts of scaling back a massive payments for ecosystem services programme in ChinaAnthony Howell
Reviews on Recent Clinical Trials|May 14, 2008
The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancerAnthony Howell
Best Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
The endocrine prevention of breast cancerAnthony Howell
BMC Medicine|November 18, 2010
Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?Anthony Howell
Cell Cycle (Georgetown, Tex.)|September 14, 2011
Defining bad stroma in human breast tumorsAnthony Howell
Behavioral Sciences (Basel, Switzerland)|January 21, 2017
Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects-A Narrative Review of Human and Animal EvidenceMichelle Harvie, Anthony Howell
Nature Medicine|November 29, 2002
Breast cancer: aromatase inhibitors take on tamoxifenMitch Dowsett, Anthony Howell
Breast Cancer Research : BCR|November 13, 2004
Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensAnthony Howell, Mitch Dowsett
Breast Cancer Research : BCR|December 25, 2009
Risk factors. Introduction to Session 1Anthony Howell, Jack Cuzick
Pageof 34